Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric (Q84028653)
Jump to navigation
Jump to search
scientific article published on 09 April 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric |
scientific article published on 09 April 2010 |
Statements
Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric effects of an aldosterone blocker in hypertensive patients with albuminuria (English)
Katsuyuki Ando
Hiroshi Ohtsu
Yoshihiro Arakawa
Kiyoshi Kubota
Takuhiro Yamaguchi
Miki Nagase
Akira Yamada
Toshiro Fujita
Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect Study Investigators